Clinical Trial

Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a central component.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2025-01-09; most recent amendment 2026-05-04.
Status change: Recruiting → Active, Not Recruiting 2026-05-04
Status change: Enrolling by Invitation → Recruiting 2025-04-24
Status change: Recruiting → Enrolling by Invitation 2025-04-07
Status change: Not Yet Recruiting → Recruiting 2025-01-22
Trial Details
NCT Number NCT06776432
Lead Sponsor Shionogi
Conditions Sleep Apnea
Enrollment 60 participants
Start Date 2025-04-02
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-06